Chemotherapeutic Strategies in Advanced or Metastatic Pancreatic Adenocarcinoma

Overview

Journal Am J Clin Oncol

Specialty Oncology

Date 2012 May 31

PMID 22643564

Citations 7

Authors

Syed F Zafar

Bassel F El-Rayes

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer remains a formidable challenge for oncologists. The only curative option remains surgical resection in early-staged disease. Cytotoxic chemotherapy offers a modest survival benefit in the advanced or metastatic stage. Clinical trials of therapy have not yet yielded encouraging outcomes in advanced pancreatic cancer. In this review, we highlight recent developments in therapy focusing on trials conducted in the advanced or metastatic setting and offer insight into the challenges for future studies.

Citing Articles

Different Survival Benefits of Chinese Medicine for Pancreatic Cancer: How to Choose?.

Li M, Wang M, Guo X, Wu C, Li D, Zhang X Chin J Integr Med. 2017; 24(3):178-184.

PMID: 29063468 DOI: 10.1007/s11655-017-2971-1.

MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts.

Zhang X, Wojtkowiak J, Martinez G, Cornnell H, Hart C, Baker A PLoS One. 2016; 11(5):e0155289.

PMID: 27227903 PMC: 4882075. DOI: 10.1371/journal.pone.0155289.

Current and future systemic treatment options in metastatic pancreatic cancer.

Arslan C, Yalcin S J Gastrointest Oncol. 2014; 5(4):280-95.

PMID: 25083302 PMC: 4110498. DOI: 10.3978/j.issn.2078-6891.2014.030.

Advanced-stage pancreatic cancer: therapy options.

Werner J, Combs S, Springfeld C, Hartwig W, Hackert T, Buchler M Nat Rev Clin Oncol. 2013; 10(6):323-33.

PMID: 23629472 DOI: 10.1038/nrclinonc.2013.66.

Enzyme inhibition of dopamine metabolism alters 6-[18F]FDOPA uptake in orthotopic pancreatic adenocarcinoma.

Tuomela J, Forsback S, Haavisto L, Vahlberg T, Gronroos T, Solin O EJNMMI Res. 2013; 3(1):18.

PMID: 23497589 PMC: 3618317. DOI: 10.1186/2191-219X-3-18.